Deciphex is accelerating pathology service delivery. Pathology is an integral part of health service delivery, it touches 95% of clinical care pathways. There is a growing supply-demand dynamic in global pathology services. A crunch point is developing due to increasing test volumes, increasing test complexity, and flat to declining pathologist numbers. The use of digital pathology (workload balancing) and artificial intelligence (process acceleration) will be a critical part of the solution for shortfalls in pathology services. Deciphex plans to be at the forefront of this revolution, networking with Pathologists from all corners of the globe to drive high-quality, efficient reporting, all while addressing the pathology productivity gap with digital pathology and AI.
Patholytix is the industry-leading digital pathology workflow & integrated AI platform for Research Pathology. Patholytix is trusted by the leading CROs and pharmaceutical companies for handling high volume drug safety pathology studies, providing a complete GLP-compliant workflow with integrated AI screening capabilities. Diagnexia is an online clinical pathology department that provides on-demand access to remote subspecialty pathologists for primary diagnostics and secondary consult services, supporting the acceleration of diagnostic turnaround times and delivery of the highest quality of patient care.
Total Funding: N/A
Funding Stage: N/A
Business Stage: Scaling Up
Market: B2B
Company Size: 51 to 100
Founded: 2017
For AI/ML Startup Founders
Get introduced to VC/PE/CVC investors
For Investors at VC/PE firms
Get introduced to AI/ML Startup founders or founders at Deciphex
Donal O'Shea
Chief Executive
Mairin Rafferty
Chief Operations Officer
Mark Gregson
Chief Technology Officer
John Nolan
Chief Commercial Officer